» Articles » PMID: 7150460

Cimetidine, but Not Oxmetidine, Penetrates into the Cerebrospinal Fluid After a Single Intravenous Dose

Overview
Specialty Pharmacology
Date 1982 Dec 1
PMID 7150460
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

1 Thirty-six patients with various neurological diseases or symptoms received single intravenous doses of either cimetidine 400 mg (n = 19) or oxmetidine 200 mg (n = 17), 15 or 60 min before a diagnostic lumbar puncture. 2 In the 15 min CSF samples concentrations of cimetidine were detectable but not measurable in 5 and non-detectable in 3 patients. 3 In the 60 min CSF samples the concentrations of cimetidine were detectable in all 11 patients and were measurable in 8 of these patients with a mean +/- s.e. mean of 0.12 +/- 0.01 microgram/ml. These CSF concentrations were correlated to simultaneously measured plasma concentrations (P less than 0.01). The mean ratio CSF/plasma concentration was 0.03. 4 No detectable concentrations of oxmetidine were found either in the 15 min (n = 9) or in the 60 min (n = 8) liquor samples. 5 Cimetidine penetrates the blood-drain barrier slowly and not freely after a single dose. Our data suggest that the new histamine H2-receptor antagonist oxmetidine does not cross this barrier.

Citing Articles

Activation of carbonic anhydrase isoforms involved in modulation of emotional memory and cognitive disorders with histamine agonists, antagonists and derivatives.

Provensi G, Nocentini A, Passani M, Blandina P, Supuran C J Enzyme Inhib Med Chem. 2021; 36(1):719-726.

PMID: 33648390 PMC: 7928026. DOI: 10.1080/14756366.2021.1891051.


normalized cimetidine-induced pituitary-testicular dysfunction: Relevance in nutraceutical therapy.

Onwuemene N, Imafidon C, Ayoka A Animal Model Exp Med. 2019; 2(3):191-200.

PMID: 31773095 PMC: 6762048. DOI: 10.1002/ame2.12081.


Using miniature brain implants in rodents for novel drug discovery.

Waldau B Expert Opin Drug Discov. 2019; 14(4):379-386.

PMID: 30831040 PMC: 9484820. DOI: 10.1080/17460441.2019.1577816.


No detectable concentrations of oxmetidine but measurable concentrations of cimetidine in cerebrospinal fluid (CSF) during multiple dose treatment.

Jonsson K, Eriksson S, Kagevi I, Norlander B, Bodemar G, Walan A Br J Clin Pharmacol. 1984; 17(6):781-2.

PMID: 6743472 PMC: 1463420. DOI: 10.1111/j.1365-2125.1984.tb02420.x.


Clinical pharmacokinetics of cimetidine.

Somogyi A, Gugler R Clin Pharmacokinet. 1983; 8(6):463-95.

PMID: 6418428 DOI: 10.2165/00003088-198308060-00001.


References
1.
Randolph W, Osborne V, WALKENSTEIN S, INTOCCIA A . High-pressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine. J Pharm Sci. 1977; 66(8):1148-50. DOI: 10.1002/jps.2600660825. View

2.
TIBBLING G, Link H, OHMAN S . Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest. 1977; 37(5):385-90. DOI: 10.1080/00365517709091496. View

3.
Lee R, Osborne P . High-pressure liquid chromatographic determination of cimetidine sulphoxide in human blood and urine. J Chromatogr. 1978; 146(2):354-60. DOI: 10.1016/s0378-4347(00)81903-9. View

4.
Bodemar G, Norlander B, Fransson L, Walan A . The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine--studies in patients with peptic ulcer disease. Br J Clin Pharmacol. 1979; 7(1):23-31. PMC: 1429608. DOI: 10.1111/j.1365-2125.1979.tb00892.x. View

5.
Schentag J, Cerra F, Calleri G, DeGlopper E, Rose J, Bernhard H . Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet. 1979; 1(8109):177-81. DOI: 10.1016/s0140-6736(79)90578-6. View